People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

When a nosebleed hits, we often go into panic mode. We frantically reach for tissues and may try shoving them up in our ...

An ear, nose and throat doctor explains why tipping your head back with a nosebleed could make things worse and what you ...

The expanded indication allows esketamine nasal spray to be used as a standalone treatment in adults with MDD who have not ...

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for ...

Many people use over-the-counter remedies to ease flu symptoms, but people with a common health condition should take care ...

The expert continued: " If your blood pressure is within a healthy range and you have no heart-related concerns, short-term use of decongestants as directed is generally safe. However, for individuals ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

In today's Health Alert, the FDA has approved the first stand-alone nasal spray to treat drug-resistant depression.